NYSE:MD Pediatrix Medical Group (MD) Stock Price, News & Analysis $21.30 +0.05 (+0.21%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$21.26 -0.04 (-0.19%) As of 05/22/2026 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Pediatrix Medical Group Stock (NYSE:MD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MD alerts:Sign Up Key Stats Today's Range$21.05▼$21.6150-Day Range$19.51▼$23.9952-Week Range$11.84▼$24.99Volume768,667 shsAverage Volume954,732 shsMarket Capitalization$1.75 billionP/E Ratio10.34Dividend YieldN/APrice Target$22.50Consensus RatingHold Company Overview Pediatrix Medical Group, Inc. (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology. Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings. Pediatrix partners with hospitals, health systems and other healthcare providers across the United States to manage patient care programs, optimize clinical outcomes and support operational efficiencies. The company’s telehealth initiatives extend critical care expertise to remote and underserved locations while its research division advances evidence-based practices in neonatal and maternal-fetal medicine. Under the leadership of President and CEO David R. Anderson, Pediatrix Medical Group emphasizes clinical quality, patient safety and physician engagement. The group supports more than 3,500 physicians and advanced practice clinicians and collaborates with over 1,300 facilities nationwide. Pediatrix continues to invest in clinical education, data analytics and population health management to meet the evolving needs of mothers, newborns and pediatric patients.AI Generated. May Contain Errors. Read More Pediatrix Medical Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreMD MarketRank™: Pediatrix Medical Group scored higher than 53% of companies evaluated by MarketBeat, and ranked 422nd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingHold Consensus RatingPediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Pediatrix Medical Group is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoveragePediatrix Medical Group has only been the subject of 4 research reports in the past 90 days.Read more about Pediatrix Medical Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth0.48% Earnings GrowthEarnings for Pediatrix Medical Group are expected to grow by 0.48% in the coming year, from $2.08 to $2.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pediatrix Medical Group is 10.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Pediatrix Medical Group is 10.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.22.Price to Book Value per Share RatioPediatrix Medical Group has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Pediatrix Medical Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.22% of the float of Pediatrix Medical Group has been sold short.Short Interest Ratio / Days to CoverPediatrix Medical Group has a short interest ratio ("days to cover") of 5.68.Change versus previous monthShort interest in Pediatrix Medical Group has recently decreased by 1.48%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPediatrix Medical Group does not currently pay a dividend.Dividend GrowthPediatrix Medical Group does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.25 News SentimentPediatrix Medical Group has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Pediatrix Medical Group this week, compared to 2 articles on an average week.Search Interest8 people have searched for MD on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.MarketBeat Follows2 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Pediatrix Medical Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $855,665.00 in company stock.Percentage Held by Insiders1.80% of the stock of Pediatrix Medical Group is held by insiders.Percentage Held by Institutions97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pediatrix Medical Group's insider trading history. Receive MD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MD Stock News HeadlinesVistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical OfficerMay 19, 2026 | businesswire.comPasskey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination PlatformMay 19, 2026 | businesswire.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.May 25 at 1:00 AM | Brownstone Research (Ad)How Investors Are Reacting To Pediatrix Medical Group (MD) Pricing‑Driven Earnings Outperformance And Margin GainsMay 18, 2026 | finance.yahoo.comPediatrix Medical Group (NYSE:MD) Director Sells $855,665.00 in StockMay 17, 2026 | americanbankingnews.comWhy Pediatrix Medical Group (MD) is a top momentum stock for the long termMay 15, 2026 | msn.comShirley Weis Sells 36,028 Shares of Pediatrix Medical Group (NYSE:MD) StockMay 15, 2026 | insidertrades.comMizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 ResultsMay 14, 2026 | insidermonkey.comSee More Headlines MD Stock Analysis - Frequently Asked Questions How have MD shares performed this year? Pediatrix Medical Group's stock was trading at $21.37 on January 1st, 2026. Since then, MD stock has decreased by 0.3% and is now trading at $21.3050. How were Pediatrix Medical Group's earnings last quarter? Pediatrix Medical Group, Inc. (NYSE:MD) posted its quarterly earnings data on Tuesday, May, 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. The business's revenue for the quarter was up 3.9% on a year-over-year basis. Read the conference call transcript. Who are Pediatrix Medical Group's major shareholders? Pediatrix Medical Group's top institutional investors include Dimensional Fund Advisors LP (4.64%), Wasatch Advisors LP (2.47%), Renaissance Technologies LLC (1.87%) and Allspring Global Investments Holdings LLC (1.17%). Insiders that own company stock include Mark S Ordan, C Marc Richards, James D Swift, Mary Ann E Moore, Michael A Rucker, Laura A Linynsky and Shirley A Weis. View institutional ownership trends. How do I buy shares of Pediatrix Medical Group? Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pediatrix Medical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD). Company Calendar Last Earnings5/05/2026Today5/25/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 MD's financial health is in the Green zone, according to TradeSmith. MD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryHealth Care Services Current SymbolNYSE:MD Previous SymbolNYSE:PDX CIK893949 Webwww.mednax.com Phone(954) 384-0175Fax954-838-9961Employees4,315Year Founded1979Price Target and Rating Average Price Target for Pediatrix Medical Group$22.50 High Price Target$27.00 Low Price Target$17.00 Potential Upside/Downside+5.6%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)$2.06 Trailing P/E Ratio10.34 Forward P/E Ratio10.24 P/E GrowthN/ANet Income$165.39 million Net Margins9.02% Pretax Margin11.76% Return on Equity19.94% Return on Assets8.02% Debt Debt-to-Equity Ratio0.45 Current Ratio1.33 Quick Ratio1.33 Sales & Book Value Annual Sales$1.91 billion Price / Sales0.91 Cash Flow$2.24 per share Price / Cash Flow9.51 Book Value$10.70 per share Price / Book1.99Miscellaneous Outstanding Shares82,120,000Free Float80,644,000Market Cap$1.75 billion OptionableOptionable Beta0.70 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NYSE:MD) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
